Ihab M. Al-masri

发表

Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.

M. Taha, Y. Bustanji, A. Al-Bakri, 2007, Journal of molecular graphics & modelling.

Discovery of DPP IV Inhibitors by Pharmacophore Modeling and QSAR Analysis followed by in silico Screening

M. Taha, Ihab M. Al-masri, M. Mohammad, 2008, ChemMedChem.

Famotidine inhibits glycogen synthase kinase-3β: An investigation by docking simulation and experimental validation

M. Taha, Y. Bustanji, Ihab M. Al-masri, 2013, Journal of enzyme inhibition and medicinal chemistry.

Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.

M. Taha, Y. Bustanji, Ihab M. Al-masri, 2008, European journal of pharmacology.

Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine

Ihab M. Al-masri, M. Mohammad, Mutasem O Tahaa, 2009, Journal of enzyme inhibition and medicinal chemistry.

In Silico Screening for Non‐nucleoside HIV‐1 Reverse Transcriptase Inhibitors Using Physicochemical Filters and High‐Throughput Docking Followed by In Vitro Evaluation

M. Taha, Y. Bustanji, A. Al-Bakri, 2009, Chemical biology & drug design.

Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents

M. Hudaib, Y. Bustanji, Ihab M. Al-masri, 2010 .

Pancreatic Lipase Inhibition by Papaverine: Investigation by Simulated Molecular Docking and Subsequent In Vitro Evaluation

Ihab M. Al-masri, 2013 .

Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article.

Ihab M. Al-masri, Mohammed T Qaoud, T. Önkol, 2021, Turkish journal of pharmaceutical sciences.

Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba

M. Hudaib, Y. Bustanji, Ihab M. Al-masri, 2011, Journal of enzyme inhibition and medicinal chemistry.

Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin.

M. Taha, Hiba M Zalloum, Y. Bustanji, 2008, Journal of medicinal chemistry.

Inhibition of pancreatic lipase by berberine and dihydroberberine: an investigation by docking simulation and experimental validation

Y. Bustanji, Ihab M. Al-masri, M. Mohammad, 2013, Medicinal Chemistry Research.

Fluoroquinolones: novel class of gastrointestinal dietary lipid digestion and absorption inhibitors

F. Afifi, Y. Bustanji, Ihab M. Al-masri, 2014, Medicinal Chemistry Research.

Design, Synthesis and Biological Evaluation of Novel Pyrazolo[1,2,4]triazolopyrimidine Derivatives as Potential Anticancer Agents

H. Deigner, D. Schollmeyer, Ihab M. Al-masri, 2021, Molecules.

Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B.

M. Taha, Y. Bustanji, Ihab M. Al-masri, 2009, Biological & pharmaceutical bulletin.

Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones

Y. Bustanji, Ihab M. Al-masri, Y. Al-Hiari, 2019, Asian Pacific journal of cancer prevention : APJCP.

Fluoroquinolones: novel class of gastrointestinal dietary lipid digestion and absorption inhibitors

F. Afifi, Y. Bustanji, Ihab M. Al-masri, 2014, Medicinal Chemistry Research.